Novavax, Inc. (FRA:NVV1)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.02B |
| Revenue (ttm) | 907.40M |
| Net Income (ttm) | 291.27M |
| Shares Out | n/a |
| EPS (ttm) | 1.76 |
| PE Ratio | 3.49 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,687 |
| Average Volume | 1,948 |
| Open | 6.46 |
| Previous Close | 6.54 |
| Day's Range | 6.39 - 6.55 |
| 52-Week Range | 4.56 - 11.23 |
| Beta | n/a |
| RSI | 62.76 |
| Earnings Date | Feb 26, 2026 |
About Novavax
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adoles... [Read more]
Financial Performance
In 2024, Novavax's revenue was $682.16 million, a decrease of -30.65% compared to the previous year's $983.71 million. Losses were -$187.50 million, -65.60% less than in 2023.
Financial numbers in USD Financial StatementsNews
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P.
Noteworthy Tuesday Option Activity: M, TEM, NVAX
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Macy's Inc (Symbol: M), where a total volume of 46,232 contracts has been traded t...
Interesting NVAX Call Options For February 2026
Investors in Novavax, Inc. (Symbol: NVAX) saw new options become available this week, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Noteworthy Tuesday Option Activity: NVAX, TKO, PYPL
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Novavax, Inc. (Symbol: NVAX), where a total of 17,942 contracts have traded so far, represe...
Pfizer leads COVID-19 vaccine peers lower after revamped guidance
Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company issues a disappointing outlook. Read more here.
Why I Wouldn't Touch Novavax With a 10-Foot Pole
This stock could be a wealth destroyer in the next five years.
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
Memo also reportedly mentions vaccines for flu and pneumonia.
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook
January 2026 Options Now Available For Novavax (NVAX)
Investors in Novavax, Inc. (Symbol: NVAX) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX opti...
Novavax, UniFirst, and More Stocks See Action From Activist Investors
Novavax rises after a seven-day slide
Notable Wednesday Option Activity: NVAX, BLK, MP
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Novavax, Inc. (Symbol: NVAX), where a total volume of 22,231 contracts has been tr...
Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Rating | NVAX Stock News
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Rating | NVAX Stock News
Oversold Conditions For Novavax (NVAX)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
Shah Capital pushes for Novavax sale, warns of proxy fight
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no progress is ...
Novavax to Participate in Jefferies London Healthcare Conference
GAITHERSBURG, Md. , Nov. 12, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Jefferies London Healthcare Confe...
Novavax, Inc. 2025 Q3 - Results - Earnings Call Presentation
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised
NVAX exceeds third-quarter expectations, boosted by a Sanofi milestone payment. It lifts its 2025 sales outlook.
Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges